Literature DB >> 10931631

Transcatheter closure of membranous ventricular septal defects with a new nitinol prosthesis in a natural swine model.

X Gu1, Y M Han, J L Titus, Z Amin, J M Berry, H Kong, C Rickers, M Urness, J L Bass.   

Abstract

Transcatheter closure of a membranous ventricular septal defect (MVSD) is much more difficult than closure of other intracardiac defects because of the proximity to the aortic and tricuspid valves and their relatively large size in small children. In this report, transcatheter closure of naturally occurring membranous VSDs was attempted in 12 Yucatan minipigs. The prosthesis is constructed from fine Nitinol wires in the shape of two buttons and a connecting waist filled with polyester fiber. Two kinds of prosthesis were used in this study: concentric and eccentric left-sided retention disks. A 6 or 7 Fr delivery sheath was advanced across the membranous VSD over a wire from femoral vein. The prosthesis was inserted through the sheath by pushing the delivery cable to deploy a button into left ventricle and the second button was then deployed into right ventricle by withdrawing the sheath. Successful implantation of the device was achieved in all animals except one. Complete closure rate was 58.3% immediately after placement, 100% at 1 week, 90.9% at 1 month and 3 months, and 100% at 6 months. An associated aneurysm of the membranous septum increased significantly in size in two of three animals using the concentric device, and in none of the animals using the eccentric device. A trace to mild aortic regurgitation was present in two of the three animals using the concentric device, and only in one of the eight animals using the eccentric device. Five animals developed a trace to mild tricuspid regurgitation. Pathologic examination showed all devices to be covered by smooth neoendothelium at 3 months. This report presents the first experimental study where closure of membranous ventricular septal defects in a swine model was attempted by specially constructed devices. Procedural success and occlusion rates are very encouraging but overall results cannot equal surgery. Further experimentation is needed with devices that are redesigned according to the experience gained from this study.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10931631     DOI: 10.1002/1522-726x(200008)50:4<502::aid-ccd29>3.0.co;2-8

Source DB:  PubMed          Journal:  Catheter Cardiovasc Interv        ISSN: 1522-1946            Impact factor:   2.692


  13 in total

Review 1.  Catheter closure of perimembranous/membranous ventricular septal defects using the Amplatzer occluder device.

Authors:  B D Thanopoulos
Journal:  Pediatr Cardiol       Date:  2005 Jul-Aug       Impact factor: 1.655

2.  Percutaneous Closure of Perimembranous Ventricular Septal Defect with Amplatzer Device.

Authors:  P Bharadwaj; A Banerji; R Datta; H Singh; A K Ghosh; G Keshavamurthy
Journal:  Med J Armed Forces India       Date:  2011-07-21

3.  Retrograde closure of perimembranous ventricular septal defect using muscular ventricular septal occluder: a single-center experience of a novel technique.

Authors:  Kalyanasundaram Muthusamy
Journal:  Pediatr Cardiol       Date:  2014-08-20       Impact factor: 1.655

4.  Percutaneous closure of perimembranous ventricular septal defects with the eccentric Amplatzer device: multicenter follow-up study.

Authors:  J Masura; W Gao; P Gavora; K Sun; A Q Zhou; S Jiang; L Ting-Liang; Y Wang
Journal:  Pediatr Cardiol       Date:  2005 May-Jun       Impact factor: 1.655

5.  Use of the Amplatzer muscular ventricular septal defect occluder for closure of perimembranous ventricular septal defects.

Authors:  M Szkutnik; S A Qureshi; J Kusa; E Rosenthal; J Bialkowski
Journal:  Heart       Date:  2006-09-15       Impact factor: 5.994

6.  Perimembranous Ventricular Septal Defect Device Closure: Choosing Between Amplatzer Duct Occluder I and II.

Authors:  Amal El-Sisi; R Sobhy; V Jaccoub; H Hamza
Journal:  Pediatr Cardiol       Date:  2017-03-01       Impact factor: 1.655

7.  Transcatheter closure of multi-hole perimembranous VSD with aneurysm: 3-year follow-up study.

Authors:  Hong Wu; Yongwen Qin; Xianxian Zhao; Jianqiang Hu; Xing Zheng; Ersong Wang; Weiping Li; Yanyan Wang; Bo Liu; Jing Liu; Shengqiang Wang
Journal:  Clin Res Cardiol       Date:  2009-07-10       Impact factor: 5.460

8.  Transcatheter closure of perimembranous ventricular septal defects with the Amplatzer asymmetric ventricular septal defect occluder: preliminary experience in children.

Authors:  B D Thanopoulos; G S Tsaousis; E Karanasios; N G Eleftherakis; C Paphitis
Journal:  Heart       Date:  2003-08       Impact factor: 5.994

9.  Transcatheter device closure of perimembranous ventricular septal defects: mid-term outcomes.

Authors:  Jian Yang; Lifang Yang; Yi Wan; Jian Zuo; Jun Zhang; Wensheng Chen; Jun Li; Lijun Sun; Shiqiang Yu; Jincheng Liu; Tao Chen; Weixun Duan; Lize Xiong; Dinghua Yi
Journal:  Eur Heart J       Date:  2010-08-27       Impact factor: 29.983

10.  A Large Institutional Study on Outcomes and Complications after Transcatheter Closure of a Perimembranous-Type Ventricular Septal Defect in 890 Cases.

Authors:  Jun Liu; Zhen Wang; Lei Gao; Hui-Lian Tan; Qinghou Zheng; Mi-Lin Zhang
Journal:  Acta Cardiol Sin       Date:  2013-05       Impact factor: 2.672

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.